ST Tian Sheng's Wholly-Owned Subsidiary's Vitamin B6 Injection Passes Generic Drug Consistency Evaluation

Regulation
โดย CLS·CN·Read original
Summary · why it matters

ST Tian Sheng announced that its wholly-owned subsidiary Hubei Tian Sheng Pharmaceutical recently received the Drug Supplementary Application Approval Notice issued by the National Medical Products Administration. The product Vitamin B6 Injection has passed the generic drug quality and efficacy consistency evaluation. This drug is mainly used for the prevention and treatment of vitamin B6 deficiency, and can also be used for vomiting caused by pregnancy, radiation sickness, and anticancer drugs. Passing the consistency evaluation this time has accumulated experience for the company's subsequent generic drug consistency evaluation work for other products.

Impact on stocks 1

Others · 1 stocks